lhcqf logo 2016
home-3-top-images-temp

Metformin

Jeffrey A Brinker, M.D.

Jeffrey A Brinker, M.D.

  • Professor of Medicine
  • Joint Appointment in Radiology and Radiological Science

https://www.hopkinsmedicine.org/profiles/results/directory/profile/0001297/jeffrey-brinker

Misuse of a substance that the Federal Air Surgeon order genuine metformin line diabetes insipidus meaning, based on case history and appropriate discount generic metformin canada diabetes symptoms muscle weakness, qualified medical judgment relating to the substance involved cheap metformin 500mg with visa diabetes insipidus rash, finds(i) Makes the person unable to safely perform the duties or exercise the privileges of the airman certificate applied for or held; or (ii) May reasonably be expected, for the maximum duration of the airman medical certificate applied for or held, to make the person unable to perform those duties or exercise those privileges. Aerospace Medical Disposition the following items list the most common conditions of aeromedical significance, and course of action that should be taken by the examiner as defined by the protocol and disposition in the table. Any additional driving offenses involving alcohol or other concerns not listed in #1?. Include any other alcohol or drug offenses, (arrests, convictions, or administrative actions) even if they were later reduced to a lower sentence. Treatment programs you attended ever in your life (if none, this should be stated) a. It should describe the circumstances surrounding the offense and any field sobriety tests that were performed. List every state/principality/location and dates you have held a driver?s license in the past 10 years. Were the records clear and in sufficient detail to permit a a certified satisfactory evaluation of the nature and extent of any previous mental disorders. Past medical history and medical problems such as Blackouts, Memory problems; Stomach, liver, cardiovascular problems or sexual dysfunction If all of the items 6. Personality changes (argumentative, combative) or Loss of self-esteem or Isolation b. Economic problems such as frequent financial crises or bankruptcy or loss of home or lack of credit f. Interpersonal Adverse Effects such as separation from family, friends, associates, etc. Include if you agree or disagree with previous diagnosis or findings from the records you reviewed and why. Specifically mention if any of the following regulatory components are present or not: a. Continued use despite damage to physical health or impairment of social, personal or occupational functioning the airman should. Any evidence of any other personality disorder, neurosis, or mental refer to their letter health condition to determine what f. Any other history pertinent to the context of the neuropsychological testing and interpretation. Discuss any weaknesses or concerning deficiencies that may potentially affect safe performance of pilot or aviation-related duties (if any). Discuss rationale and interpretation of any additional testing that was performed. Submit your report along with the CogScreen computerized summary report (approximately 13 pages) and summary score sheet for all additional testing performed. Drug and/or alcohol testing results summarized, how often tested, how many tests performed to date. Continued use despite damage to physical health or impairment of social, personal, or occupational functioning. Department of Transportation; or 3) Misuse of a substance that the Federal Air Surgeon, based on case history and appropriate, qualified medical judgment relating to the substance involved, finds: (i) Makes the person unable to safely perform the duties or exercise the privileges of the airman certificate applied for or held; or (ii) May reasonably be expected, for the maximum duration of the airman medical certificate applied for or held, to make the person unable to perform those duties or exercise those privileges. Convictions; or 403 Guide for Aviation Medical Examiners C. The 8500-8 specifically asks the airman to report if they ?ever in their life have been diagnosed with, had, or presently have. In some cases, additional information will be required before a medical certificate may be issued. If none have occurred, that should be noted in Block 60 per the disposition table. If the airman is on a Special Issuance for drug or alcohol condition(s) and they have a new event, they should not fly under 61. The airman must take a separate action to report a conviction or administrative action to security. Upon receipt and review of all of the above information, additional information or action may be requested. It may be listed in a hospital report, a police report or Blood Alcohol investigative report. Submit a complete copy of your driving records from each of these for the past 10 years. If no program was recommended or if treatment was started but not completed, that should be stated. If each item is not addressed by the corresponding provider there may be a delay in the processing of your medical certification until that information is submitted. Any evidence (such as a positive test) or concern the airman has not remained abstinent? Describe how the airman is doing in the program and if he/she is engaged in recovery. Legal problems such as Alcohol-related traffic offenses or Public intoxication, Assault and battery d. Occupational problems such as absenteeism or tardiness at work; reduced productivity, demotions or frequent job changes or loss of job.

buy cheap metformin

Standardized questionnaires were administered in the home discount metformin american express diabetes mellitus blood sugar levels, followed by a detailed physical examination at a Mobile Examination Center buy cheap metformin 500mg line diabetes symptoms negative test. Data on physiologic variation in creatinine were obtained in a sample of 1 purchase 500mg metformin visa blood glucose app,921 participants who had a repeat creatinine measurement. The percent difference between the two creatinine measurements, a mean of 17 days apart, had a mean of 0. The mean serum creatinine for 20 to 39-yearold participants without hypertension or diabetes was 1. College of American Pathologists Survey data, released with permission of both laboratories, show that creatinine values in the White Sands laboratory measured during 1992 to 1995 using the Hitachi 737 instrument averaged 0. The latter values were similar to the overall mean of all laboratories for creatinine. Statistics focused on percentiles of the distribution to further decrease the influence of such outliers. Proteinuria A random spot urine sample was obtained from each participant aged 6 years and older, using a clear catch technique and sterile containers. Urine samples were placed on dry ice and shipped overnight to a central laboratory where they were stored at 20 C. Urinary albumin concentration was measured by solid-phase fluorescent immunoassay. Sex specific cutoffs were used to define microalbuminuria and albuminuria in a single spot urine. Our estimates reflect the prevalence of albuminuria based on a single untimed urine specimen and include individuals with persistent albuminuria and individuals with inter280 Part 10. Agreement between the initial and repeat tests classified as normal, micro, and macro albuminuria was 91. Microalbuminuria persisted in the second visit in 57% and macroalbuminuria was present in another 4% of the 110 participants with microalbuminuria on the first exam. The variation in persistence by age group and sexwas: 45% at 20 to 39 (n 22), 59% at 40 to 59 (n 32), 70% at 60 to 79 (n 43), and 44% at 80 years (n 9), 65% among men (n 48), and 52% among women (n 62). Among 1,099 individuals without microalbuminuria at the first visit 5% (n 56) had microalbuminuria or albuminuria on the second visit. Blood Pressure Blood pressure measurements were obtained three times during the home interview and another three times during the examination and averaged. Individuals were classified as hypertensive if they had a mean blood pressure 140 mm Hg systolic, or 90 mm Hg diastolic, or reported being currently prescribed medication for hypertension treatment. The primary analysis stratified individuals based on a history of diagnosed diabetes mellitus since this information was available for nearly all individuals and could be used by physicians for risk stratification. Dietary History Dietary history was collected using a food frequency questionnaire. To derive national estimates, sampling weights are used to adjust for non-coverage and non-response. Appendices 281 (individuals missing data were 4 years older), among men than women (17. To minimize bias the combined Mobile Examination Center and home exam weights were divided by the proportion of participants missing creatinine data in each of the design age, sex, and race ethnicity strata. This corrects differences in missing data across sampling strata but assumes that data are missing randomly within strata. Missing data rates for other covariates among these individuals varied from 0% for serum albumin to 4. To allow for non-linear associations with age, age adjustment used a fifth order polynomial. Regressions were weighted using the sampling weights but quantile regression did not allow for explicit incorporation of survey strata into calculation of standard errors. The results are presented in graphical format as regression along with 95% confidence intervals for selected points in the age-adjusted regression. The prevalence of abnormality in each category was calculated for two cutoff values. For example, with blood hemoglobin as the covariate, the cutoffs were 11 g/dL and 13 g/dL. Prevalence estimates were age adjusted using logistic regression to avoid confounding by age. Logistic regressions incorporating sample weights and the complex survey design were fit separately for each outcome (for example serum albumin 3. The regression was then used to predict the prevalence for a 60-year-old person with all other covariates unchanged. Some of the figures label this estimate as ?mL/min, although it should more correctly be labeled ?mL/min/1. A smaller sample size was permitted for pediatric studies because large pediatric studies are rare. The median difference provides a measure that is valid and less susceptible to influence by outliers. Clinically this is relevant, as there is less concern about the difference between 100 and 130 mL/min/1. Second, correlation measures ignore bias and measure relative rather than absolute agreement. First, ordinary least square regression does not allow for measurement error in the X-variable. As a result, the regression equation provides a prediction equation conditional of the X-value rather than an unbiased estimate of the relationship. The importance of measurement error in the X-values depends on the correlation, which in turn depends on the study population. Exclusion of these analytes decreases the cost of testing, the susceptibility to bias in calibration of these other analytes, and bias due to alteration of these analyses by diseases other than kidney disease.

Buy cheap metformin. মাত্র ৫ মিনিটে ডায়াবেটিস ধ্বংস করুন ।। ডায়াবেটিস নিয়ন্ত্রণের উপায় ।। Diabetes treatment.

metformin 500mg otc

Your doctor and a swallowing therapist can tailor strategies to your specifc situation purchase metformin with mastercard diabetes type 1 without insulin, which may include: Over-the-counter antacids Available without a prescription cheap 500 mg metformin with mastercard diabetes puppy signs, these include such products as Alka-Seltzer? purchase metformin on line amex diabetes insipidus in cats, Maalox?, Mylanta?, Pepto-Bismol?, Rolaids and Riopan?. Foaming agents these drugs, such as Gaviscon?, work by covering your stomach contents with foam to prevent refux. They are available over-the-counter and in prescription strength, but long-term use should only be undertaken with the supervision of your physician. These include omeprazole (Prilosec ), lansoprazole (Prevacid ), pantoprazole (Protonix ?), rabeprazole (Aciphex ) and esomeprazole (Nexium ?). Prokinetics Another group of medications, prokinetics help strengthen the sphincter and make the stomach empty faster. Also, long-term use should only be undertaken with your physician?s supervision. Because medications work in different ways, combinations of drugs may be the best approach to controlling your symptoms. This fundoplication procedure may be done with small cuts in the abdomen and the use of a thin, lighted instrument that holds a tiny camera (laparoscope). The procedure has been safely and effectively performed in patients of all ages, and most patients are satisfed with the results when undertaken for the right reasons. This can be done successfully when the valve mechanism created by the frst fundoplication is no longer effective. However, results of repeat operations are more variable and must be performed at experienced high volume centers. Barrett?s esophagus is the result of acid irritation of the tissue lining the esophagus. This irritation causes the tissue cells to be replaced by a type of cell not normally found there. Although that risk is very small (less than 1 percent), patients with Barrett?s esophagus should be regularly monitored for changes that may indicate the development of this cancer. Men develop the disease twice as often as women, and white men are hand-in-hand with our colleagues affected more frequently than those of other races. Other risk factors include at Cleveland Clinic?s Taussig obesity, increasing age and family history. Taussig Cancer Institute experts provide the most leading-edge How is Barrett?s esophagus care to patients with cancer, and are at the forefront of new and diagnosed? A gastroenterologist (a doctor specializing can help answer questions you in digestive diseases) or a surgeon performs this test. The doctor inserts a small, have about cancer, schedule fexible tube with a light down the esophagus. A tiny camera mounted on the end appointments for consultation transmits a video image that allows the doctor to closely examine the lining of the with a physician, provide a cancer esophagus. These tissue samples are then closely examined in a laboratory under a microscope to To speak with a cancer nurse determine whether Barrett?s esophagus cells are present. Barrett?s esophagus can lead to cancer of the esophagus in a small number of patients. Roughly 1 in 300 patients with Barrett?s esophagus will develop esophageal cancer each year. This cancer, adenocarcinoma, develops through a series of precancerous changes in the cells of the esophagus. These changes are known as dysplasia, and the condition is classifed as low grade (slight cellular change) or high grade (moderate to severe cellular change). Because of the cancer risk, patients with Barrett?s esophagus should have endoscopies at regular intervals. This is known as surveillance, and will help detect any cancer at an early and potentially curable stage. It also may include medications, called proton pump inhibitors, to block the formation of acid. The medication is used to prevent further damage and typically is taken once or twice a day, with meals. They Institute At Cleveland Clinic, identifed do not work effectively when taken intermittently. This There are several possible treatments that specifcally focus on the abnormal tisis considered a signifcant genetic sue found in Barrett?s esophagus: predisposition to the diseases. An electrode mounted on a balloon or Identifying these genes also gives endoscope sends heat to the Barrett?s tissue, destroying the cells. The lining is then risk assessment, disease management removed through the endoscope. Expertise in diagnosis and removal, the esophagus is rebuilt from part of the stomach or large intestine. The muscle at the lower end of the esophagus stays closed during next follow-up surveillance date swallowing. Other symptoms include diffculty swallowing, vomiting of undigested clinical research programs food, chest pain, heartburn and weight loss. These nerves are attacked by the patient?s own immune Barrett?s Esophagus Consortium system and slowly degenerate. Research Program for patients with a family history of Barrett?s esophagus or esophageal cancer.

buy cheap metformin on-line

Depending on the subject matter order metformin cheap online diabetes medications for dogs, a series of lectures buy 500mg metformin mastercard diabetes mellitus definition classification and diagnosis, discussions order metformin visa diabetes mellitus specific gravity, films, and group therapy sessions are led by either physicians, psychologists, or alcoholism counselors from the hospital or various outside organizations. Patients may directly enter an inpatient hospital rehabilitation program after having undergone detoxification in the same hospital or in another hospital or may enter an inpatient hospital rehabilitation program without prior hospitalization for detoxification. Alcohol rehabilitation can be provided in a variety of settings other than the hospital setting. In order for an inpatient hospital stay for alcohol rehabilitation to be covered under Medicare it must be medically necessary for the care to be provided in the inpatient hospital setting rather than in a less costly facility or on an outpatient basis. Inpatient hospital care for receipt of an alcohol rehabilitation program would generally be medically necessary where either (l) there is documentation by the physician that recent alcohol rehabilitation services in a less intensive setting or on an outpatient basis have proven unsuccessful and, as a consequence, the patient requires the supervision and intensity of services which can only be found in the controlled environment of the hospital, or (2) only the hospital environment can assure the medical management or control of the patient?s concomitant conditions during the course of alcohol rehabilitation. Since alcoholism is classifiable as a psychiatric condition the ?active treatment criteria must also be met in order for alcohol rehabilitation services to be covered under Medicare. An inpatient hospital stay for alcohol rehabilitation may be extended beyond this limit in an individual case where a longer period of alcohol rehabilitation is medically necessary. In such cases, however, there should be documentation by a physician which substantiates the need for such care. Where the rehabilitation needs of an individual no longer require an inpatient hospital setting, coverage should be denied on the basis that inpatient hospital care is not reasonable and necessary as required by ?1862 (a)(l) of the Act. Subsequent admissions to the inpatient hospital setting for alcohol rehabilitation follow-up, reinforcement, or ?recap treatments are considered to be readmissions (rather than an extension of the original stay) and must meet the requirements of this section for coverage under Medicare. Prior admissions to the inpatient hospital setting either in the same hospital or in a different hospital may be an indication that the ?active treatment requirements are not met. Accordingly, there should be documentation to establish that ?readmission to the hospital setting for alcohol rehabilitation services can reasonably be expected to result in improvement of the patient?s condition. For example, the documentation should indicate what changes in the patient?s medical condition, social or emotional status, or treatment plan make improvement likely, or why the patient?s initial hospital treatment was not sufficient. Not all patients who require the inpatient hospital setting for detoxification also need the inpatient hospital setting for rehabilitation. These services may include, for example, drug therapy, psychotherapy, and patient education and may be furnished by physicians, psychologists, nurses, and alcoholism counselors to individuals who have been discharged from an inpatient hospital stay for treatment of alcoholism and require continued treatment or to individuals from the community who require treatment but do not require the inpatient hospital setting. Coverage is available for both diagnostic and therapeutic services furnished for the treatment of alcoholism by the hospital to outpatients subject to the same rules applicable to outpatient hospital services in general (see the Medicare Benefit Policy Manual, Chapter 6, ?Hospital Services Covered Under Part B, ?20). While there is no coverage for day hospitalization programs, per se, individual services which meet the requirements in the Medicare Benefit Policy Manual, Chapter 6, ?Hospital Services Covered Under Part B, ?20 may be covered. Thus, educational services and family counseling would only be covered where they are directly related to treatment of the patient?s condition. Chemical aversion therapy facilitates alcohol abstinence through the development of conditioned aversions to the taste, smell, and sight of alcohol beverages. While a number of drugs have been employed in chemical aversion therapy, the three most commonly used are emetine, apomorphine, and lithium. None of the drugs being used, however, have yet been approved by the Food and Drug Administration specifically for use in chemical aversion therapy for alcoholism. Accordingly, when these drugs are being employed in conjunction with this therapy, patients undergoing this treatment need to be kept under medical observation. Available evidence indicates that chemical aversion therapy may be an effective component of certain alcoholism treatment programs, particularly as part of multi-modality treatment programs which include other behavioral techniques and therapies, such as psychotherapy. Based on this evidence, the Centers for Medicare & Medicaid Services medical consultants have recommended that chemical aversion therapy be covered under Medicare. However, since chemical aversion therapy is a demanding therapy which may not be appropriate for all Medicare beneficiaries needing treatment for alcoholism, a physician should certify to the appropriateness of chemical aversion therapy in the individual case. Therefore, if chemical aversion therapy for treatment of alcoholism is determined to be reasonable and necessary for an individual patient, it is covered under Medicare. When it is medically necessary for a patient to receive chemical aversion therapy as a hospital inpatient, coverage for care in that setting is available. Thus, where a patient is admitted as an inpatient for receipt of chemical aversion therapy, there must be documentation by the physician of the need in the individual case for the inpatient hospital admission. Electrical aversion therapy is a behavior modification technique to foster abstinence from ingestion of alcoholic beverages by developing in a patient conditioned aversions to their taste, smell and sight through electric stimulation. Electrical aversion therapy has not been shown to be safe and effective and therefore is excluded from coverage. The coverage available for these services is subject to the same rules generally applicable to the coverage of clinic services. Of course, the services also must be reasonable and necessary for the diagnosis or treatment of the individual?s alcoholism or drug abuse. The Part B psychiatric limitation (see the Medicare General Information, Eligibility, and Entitlement Manual, Chapter 3, ?Deductibles, Coinsurance Amounts, and Payment Limitations, ?30) would apply to alcoholism or drug abuse treatment services furnished by physicians to individuals who are not hospital inpatients. However, the intensity and duration of treatment for drug abuse may vary (depending on the particular substance(s) of abuse, duration of use, and the patient?s medical and emotional condition) from the duration of treatment or intensity needed to treat alcoholism. Accordingly, when it is medically necessary for a patient to receive detoxification and/or rehabilitation for drug substance abuse as a hospital inpatient, coverage for care in that setting is available. Coverage is also available for treatment services that are provided in the outpatient department of a hospital to patients who, for example, have been discharged from an inpatient stay for the treatment of drug substance abuse or who require treatment but do not require the availability and intensity of services found only in the inpatient hospital setting. The coverage available for these services is subject to the same rules generally applicable to the coverage of outpatient hospital services. Drugs that the physician provides in connection with this treatment are also covered if they cannot be selfadministered and meet all other statutory requirements. Cross-reference: Medicare Benefit Policy Manual, Chapter 6, ?Hospital Services Covered Under Part B, ?20. In the case where a woman suffers from a physical disorder, physical injury, or physical illness, including a life-endangering physical condition caused by or arising from the pregnancy itself, that would, as certified by a physician, place the woman in danger of death unless an abortion is performed.

Endoscopic papillary balloon dilatation versus endoscopic 136 Giovannini M purchase metformin 500 mg with visa diabetic diet us, Moutardier V discount metformin uk diabetes medicine onglyza, Pesenti C buy discount metformin 500mg on-line diabetes mellitus with hypoglycemic coma code, et al. Endoscopic ultrasound-guided sphincterotomy in the treatment for choledocholithiasis: a meta-analysis. Endoscopic Ultrasound-Guided Biliary balloon dilatation and endoscopic sphincteropapillotomy. Bacteriological study of choledochal bile 109 Neuhaus H, Hoffmann W, Zillinger C, et al. Biliary endoprostheses in elderly patients patients requiring evaluation of bile duct disease or therapy of biliary stones (with with endoscopically irretrievable common bile duct stones: report on 117 patients. Biliary tract diseases in the elderly: management and endoprosthesis versus duct clearance for bileduct stones in high-risk patients. Biliary lithiasis in the elderly patient: morbidity 141 Di Giorgio P, Manes G, Grimaldi E, et al. Optimal timing of endoscopic retrograde prospective randomized study of endoscopic versus surgical treatment of bile duct cholangiopancreatography in acute cholangitis. Variations in implementation of current national sphincterotomy with gallbladder left in situ versus open surgery for common guidelines for the treatment of acute pancreatitis: implications for acute surgical bileduct calculi in high-risk patients. An audit of the management of symptomatic patients with suspected common bile duct stones: a multicenter patients with acute pancreatitis against national standards of practice. Wait-and-see policy or laparoscopic strategy versus early conservative management strategy in acute gallstone cholecystectomy after endoscopic sphincterotomy for bile-duct stones: a pancreatitis. Cholecystectomy or gallbladder in situ after pancreatitis: outcomes of cholecystectomy on? Should prophylactic cholecystectomy be performed in mild biliary pancreatitis: a systematic review. Endoscopic sphincterotomy and co-existing gallbladder stones: a prospective randomised trial. The relationship between gallbladder status and and endoscopic sphincterotomy in the management of gallstone pancreatitis. Surg recurrent biliary complications in patients with choledocholithiasis following Endosc 2014;28:127?33. Endoscopic Retrograde Cholangiopancreatography in Gastroenterol Hepatol 2007;5:130?7. Risk factors of acute cholecystitis after endoscopic comparative study of the forward-viewing endoscope and the side-viewing common bile duct stone removal. Long-term follow-up study of gallbladder in situ after 183 Cicek B, Parlak E, Disibeyaz S, et al. A randomized trial of endoscopic duct stones in patients with gallbladder in situ? Korean J Intern Med balloon dilation and endoscopic sphincterotomy for removal of bile duct stones 2001;16:254?9. Endoscopic Papillary Large Balloon Dilation Combined with Endoscopy 2002;34:273?9. Endoscopic treatment of bile duct calculi with surgically altered pancreaticobiliary anatomy (with video). Gastrointest Endosc in patients with gallbladder in situ: long-term outcome and factors. Complications of endoscopic biliary gastrostomy tube placement in patients with Roux-en-Y gastric bypass: a novel sphincterotomy. To date, ?Enhanced Image Endoscopy has become our routine practice and we can see what we did not clearly before. All clinical contexts are well relevant to the current practice and can be utilized easily. Needless to say, I would like to express my deeply thank to the editors, Professor Rungsun Rerknimitr, Dr. Linda Pantongrag-Brown, Associated Professor Sombat Treeprasertsuk, and all contributors for their great efforts to create this fascinating book. We are grateful to all contributors for their excellent support to make this atlas happens. Last but not least, please do not forget to visit us and download all previous issues from our website. Nuttaporn Norrasetwanich Division of Gastroenterology, Department of Medicine, Division of Gastroenterology, Department of Medicine, Chulalongkorn University, Bangkok, Thailand Chulalongkorn University, Bangkok, Thailand 2. Phonthep Angsuwatcharakon Division of Gastroenterology, Department of Medicine, Department of Anatomy, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Chulalongkorn University, Bangkok, Thailand 3. Piyapan Prueksapanich Division of Gastroenterology, Department of Medicine, Division of Gastroenterology, Department of Medicine, Chulalongkorn University, Bangkok, Thailand Chulalongkorn University, Bangkok, Thailand 4. Pornphan Thienchanachaiya Division of Gastroenterology, Department of Medicine, Division of Gastroenterology, Department of Medicine, Chulalongkorn University, Bangkok, Thailand Chulalongkorn University, Bangkok, Thailand 5. Rapat Pittayanon Chulalongkorn University, Bangkok, Thailand Division of Gastroenterology, Department of Medicine, Chulalongkorn University, Bangkok, Thailand 7. Naruemon Wisedopas-Klaikeaw Department of Pathology, Chulalongkorn University, 16. Rungsun Rerknimitr Bangkok, Thailand Division of Gastroenterology, Department of Medicine, Chulalongkorn University, Bangkok, Thailand 8.

References:

  • https://bizwest.com/wp-content/uploads/2018/04/2018_BOL_flyp.pdf
  • https://2012-2017.usaid.gov/sites/default/files/documents/1866/DRG-Users-Guide-8.08.2017.pdf
  • https://www.ahajournals.org/doi/10.1161/CIR.0b013e31828478ac
  • http://blogs.egusd.net/batey/files/2012/09/BookLevel312-vxd9p1.pdf
  • https://radicalfeministbookclub.files.wordpress.com/2018/03/women-and-history-gerda-lerner-the-creation-of-feminist-consciousness_-from-the-middle-ages-to-eighteen-seventy-oxford-university-press-1993.pdf
 
 
footer-top-line
> CONTACT INFORMATION

    Louisiana Health Care Quality Forum

    8550 United Plaza Blvd., Ste. 301
    Baton Rouge, Louisiana 70809

    info@lhcqf.org
    Ph (225) 334-9299 | Fax 225-334-9847

facebook-logotwitter-logolinkedin-logoyoutube-logo
 
side-nav-off 01
side-nav-off 02
side-nav-off 03
side-nav-off 04
 

Loading